Global Pulmonary Drugs Market Data Survey Report 2013-2025

Table of Contents

1 Global Market Overview

• 1.1 Scope of Statistics
  • 1.1.1 Scope of Products
  • 1.1.2 Scope of Manufacturers
  • 1.1.3 Scope of Application
  • 1.1.4 Scope of Type
  • 1.1.5 Scope of Regions/Countries
• 1.2 Global Market Size

2 Regional Market

• 2.1 Regional Production
• 2.2 Regional Demand
• 2.3 Regional Trade

3 Key Manufacturers

• 3.1 AstraZeneca plc
  • 3.1.1 Company Information
  • 3.1.2 Product & Services
  • 3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.1.4 Recent Development
• 3.2 Bayer AG
  • 3.2.1 Company Information
  • 3.2.2 Product & Services
  • 3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.2.4 Recent Development
• 3.3 Teva Pharmaceutical Industries Ltd
  • 3.3.1 Company Information
  • 3.3.2 Product & Services
  • 3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.3.4 Recent Development
• 3.4 Actelion Pharmaceuticals, Inc.
  • 3.4.1 Company Information
  • 3.4.2 Product & Services
  • 3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.4.4 Recent Development
• 3.5 Boehringer Ingelheim GmbH
  • 3.5.1 Company Information
  • 3.5.2 Product & Services
  • 3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.5.4 Recent Development
• 3.6 F. Hoffmann-La Roche Ltd.
  • 3.6.1 Company Information
  • 3.6.2 Product & Services
  • 3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.6.4 Recent Development
• 3.7 Merck & Co., Inc.
  • 3.7.1 Company Information
  • 3.7.2 Product & Services
  • 3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.7.4 Recent Development
• 3.8 Novartis AG
  • 3.8.1 Company Information
  • 3.8.2 Product & Services
  • 3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.8.4 Recent Development
• 3.9 GlaxoSmithKline plc
  • 3.9.1 Company Information
  • 3.9.2 Product & Services
  • 3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.10 Sunovion Pharmaceuticals
  • 3.10.1 Company Information
  • 3.10.2 Product & Services
  • 3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 Major Application

• 4.1 Asthma & COPD
  • 4.1.1 Overview
  • 4.1.2 Asthma & COPD Market Size and Forecast
• 4.2 Allergic Rhinitis
  • 4.2.1 Overview
  • 4.2.2 Allergic Rhinitis Market Size and Forecast
• 4.3 Pulmonary Arterial Hypertension
  • 4.3.1 Overview
  • 4.3.2 Pulmonary Arterial Hypertension Market Size and Forecast
• 4.4 Cystic Fibrosis
  • 4.4.1 Overview
  • 4.4.2 Cystic Fibrosis Market Size and Forecast

5 Market by Type

5.By Inhaled Corticosteroids (ICS)

• 5.1 Inhaled Corticosteroids (ICS)
  • 5.1.1 Overview
  • 5.1.2 Inhaled Corticosteroids (ICS) Market Size and Forecast
• 5.2 Long-Acting Beta2-Agonists (LABA)
  • 5.2.1 Overview
  • 5.2.2 Long-Acting Beta2-Agonists (LABA) Market Size and Forecast
• 5.3 Antihistamine
  • 5.3.1 Overview
  • 5.3.2 Antihistamine Market Size and Forecast
• 5.4 Vasodilators
  • 5.4.1 Overview
  • 5.4.2 Vasodilators Market Size and Forecast
• 5.5 Short-Acting Beta2-Agonists (SABA)
  • 5.5.1 Overview
  • 5.5.2 Short-Acting Beta2-Agonists (SABA) Market Size and Forecast
• 5.6 Anticholinergics
  • 5.6.1 Overview
  • 5.6.2 Anticholinergics Market Size and Forecast
• 5.7 Combination Drugs
  • 5.7.1 Overview
  • 5.7.2 Combination Drugs Market Size and Forecast
• 5.8 MAbs
  • 5.8.1 Overview
  • 5.8.2 MAbs Market Size and Forecast
• 5.9 Enzymes
  • 5.9.1 Overview
  • 5.9.2 Enzymes Market Size and Forecast
• 5.10 Antibiotics & Antileukotrienes
  • 5.10.1 Overview
  • 5.10.2 Antibiotics & Antileukotrienes Market Size and Forecast

6 Price Overview

• 6.1 Price by Manufacturers
• 6.2 Price by Application
• 6.3 Price by Type

7 Conclusion